The 5th Annual Cholangiocarcinoma Foundation Conference brought together nearly 370 patients, caregivers, physicians, researchers, industry, government, allied non-profit partners and others invested in the study of bile duct cancer from 96 U.S. and international organizations.
Representatives from 12 countries and 40 states were in attendance. The event featured 54 patient-focused, clinical and pre-clinical presentations over three days, plus a poster session, patient and industry engagement sessions, an industry forum, ancillary medical advisor meetings, and many informal networking opportunities.
Funding for this conference was made possible (in part) by a Eugene Washington Engagement Award from the Patient-Centered Outcomes Research Institute (PCORI) allowing 30 patients from around the world to take part in all facets of the conference including speaking, attending sessions, roundtable discussions, and networking events.
Funding for this conference was made possible (in part) by 1R13CA213778-01 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.